Withdrawal of immunosuppression in liver allograft recipients
- 1 May 1998
- journal article
- review article
- Published by Wiley in Liver Transplantation and Surgery
- Vol. 4 (3), 242-248
- https://doi.org/10.1002/lt.500040309
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- ROLE OF STEROID DOSE IN HYPERTENSION EARLY AFTER LIVER TRANSPLANTATION WITH TACROLIMUS (FK506) AND CYCLOSPORINE1Transplantation, 1996
- Incidence of rejection and infection after liver transplantation as a function of the primary disease: Possible influence of alcohol and polyclonal immunoglobulinsHepatology, 1996
- A RANDOMIZED PROSPECTIVE TRIAL OF STEROID WITHDRAWAL AFTER LIVER TRANSPLANTATION1,2Transplantation, 1995
- Corticosteroid withdrawal after liver transplantationSurgery, 1995
- Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejectionHepatology, 1994
- TRENDS IN THE USE OF GLUCOCORTICOIDS IN RENAL TRANSPLANTATIONTransplantation, 1994
- MONOTHERAPY WITH CYCLOSPORINE FOR CHRONIC IMMUNOSUPPRESSION IN PEDIATRIC LIVER TRANSPLANT RECIPIENTSTransplantation, 1994
- Pulse corticosteroid therapy increases viremia (HCV RNA) in patients with chronic HCV infection . Division of Gastroenterology/Hepatology, Scripps Clinic and Research Foundation, La Jolla Ca and Chiron Corporation, Emeryville, CAHepatology, 1993
- STEROID WITHDRAWAL FROM LONG-TERM IMMUNOSUPPRESSION IN LIVER ALLOGRAFT RECIPIENTSTransplantation, 1993
- Rejection in liver transplantationHepatology, 1989